AU2003278935A1 - Method and composition for treating neurodegenerative disorders - Google Patents
Method and composition for treating neurodegenerative disordersInfo
- Publication number
- AU2003278935A1 AU2003278935A1 AU2003278935A AU2003278935A AU2003278935A1 AU 2003278935 A1 AU2003278935 A1 AU 2003278935A1 AU 2003278935 A AU2003278935 A AU 2003278935A AU 2003278935 A AU2003278935 A AU 2003278935A AU 2003278935 A1 AU2003278935 A1 AU 2003278935A1
- Authority
- AU
- Australia
- Prior art keywords
- composition
- neurodegenerative disorders
- treating neurodegenerative
- treating
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41404502P | 2002-09-26 | 2002-09-26 | |
| US60/414,045 | 2002-09-26 | ||
| PCT/US2003/030284 WO2004028456A2 (en) | 2002-09-26 | 2003-09-26 | Method and composition for treating neurodegenerative disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003278935A1 true AU2003278935A1 (en) | 2004-04-19 |
| AU2003278935A8 AU2003278935A8 (en) | 2004-04-19 |
Family
ID=32043333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003278935A Abandoned AU2003278935A1 (en) | 2002-09-26 | 2003-09-26 | Method and composition for treating neurodegenerative disorders |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003278935A1 (en) |
| WO (1) | WO2004028456A2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4901474B2 (en) | 2003-05-30 | 2012-03-21 | ランバクシー ラボラトリーズ リミテッド | Substituted pyrrole derivatives |
| WO2006001877A2 (en) * | 2004-04-13 | 2006-01-05 | Myriad Genetics, Inc. | Combination treatment for neurodegenerative disorders comprising r-flurbiprofen |
| AU2006313430B2 (en) * | 2005-11-08 | 2012-09-06 | Ranbaxy Laboratories Limited | Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
| CN104368002B (en) * | 2014-10-17 | 2019-01-08 | 中国人民解放军军事医学科学院毒物药物研究所 | For treating the combination medicine of dull-witted or cognition dysfunction |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6365180B1 (en) * | 1998-01-20 | 2002-04-02 | Glenn A. Meyer | Oral liquid compositions |
| US6383471B1 (en) * | 1999-04-06 | 2002-05-07 | Lipocine, Inc. | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents |
-
2003
- 2003-09-26 AU AU2003278935A patent/AU2003278935A1/en not_active Abandoned
- 2003-09-26 WO PCT/US2003/030284 patent/WO2004028456A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004028456A2 (en) | 2004-04-08 |
| WO2004028456A3 (en) | 2004-06-17 |
| AU2003278935A8 (en) | 2004-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1603548A4 (en) | Method and composition for treating neurodegenerative disorders | |
| AU2003216379A1 (en) | Method for treating otic disorders | |
| IL208191A0 (en) | Compositions and methods for treating rage-associated disorders | |
| EP1651164A4 (en) | Composition and method for treating neurological disorders | |
| AU2003286611A1 (en) | Cytomodulating peptides and methods for treating neurological disorders | |
| AUPS323902A0 (en) | Compositions and methods for treating gynaecological disorders | |
| AU2003297762A1 (en) | Methods for treating essential tremor | |
| AU7085100A (en) | Method for treating otic disorders | |
| AU2003230750A1 (en) | Compositions and methods for treating cancer | |
| AU2002329022A1 (en) | Method and pharmaceutical composition for treating inflammation | |
| AU2003225535A1 (en) | Methods and compositions for treating cancer | |
| AU2003210597A1 (en) | Methods for treating eye disorders | |
| EP1567198A4 (en) | Materials and methods for treating ocular-related disorders | |
| AUPS236902A0 (en) | Composition and method for treating hypertension | |
| AU2003268032A1 (en) | Composition and methods for treatment and screening | |
| AU2003232044A1 (en) | Composition and method for dermatological treatment | |
| AU2003296968A1 (en) | Method and apparatus for preventing and treating eyelid problems | |
| AU2002363935A1 (en) | Composition and method for the treatment of anorectal disorders | |
| AU2003262840A1 (en) | Composition and method for treating skin | |
| AU2003278935A1 (en) | Method and composition for treating neurodegenerative disorders | |
| AU2003214920A1 (en) | Methods and compositions for treating hematological disorders | |
| AU2003291730A1 (en) | Methods and compositions for treating neurodegenerative diseases | |
| AU2003275433A1 (en) | Compositions and methods for treating pain | |
| EP1594473A4 (en) | Composition and method for treating age-related disorders | |
| AU2003297259A1 (en) | Methods and compositions for treating neurological disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |